Zobrazeno 1 - 10
of 23
pro vyhledávání: '"S. A. Bogomaz"'
Publikováno v:
Вестник Кемеровского государственного университета, Vol 22, Iss 4, Pp 1028-1039 (2021)
The article addresses the issues associated with increasing the reliability of research tools for value orientation studies. Despite the high demand, their methodology requires qualitative improvement. The research objective was to determine the psyc
Externí odkaz:
https://doaj.org/article/3b762fad05744f88ab5e97de3d2a7a2d
Publikováno v:
Вестник Кемеровского государственного университета, Vol 0, Iss 3-3, Pp 88-92 (2015)
The purpose of the study was to discover the correlation between students‘ subjective evaluation of the feasibility of the basic values in the university educational environment and the degree of manifestation of their implicit theories of intellig
Externí odkaz:
https://doaj.org/article/d967d9a5956f4613a0710a12b63c5dd3
Autor:
N V, Solenkova, L N, Maslov, V Iu, Serebrov, A Iu, Lishmanov, S A, Bogomaz, G J, Gross, G J, Grover
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 67(3)
Opening of the ATP-dependent K-channels (K(ATP) channels) upon intravenous administration of the cardioselective activator BMS 180448 (3 mg/kg) decreased the ventricular fibrillation threshold (VFT) in rats with postinfarction cardiosclerosis (PIC).
Autor:
Iu B, Lishmanov, N V, Naryzhnaia, A V, Krylatov, L N, Maslov, S A, Bogomaz, D S, Ugdyzhekova, G J, Gross, J B, Stefano
Publikováno v:
Izvestiia Akademii nauk. Seriia biologicheskaia. (6)
Preliminary stimulation of opiate receptors (ORs) by intravenous administration of mu agonist DALDA (0.5 mg/kg), delta 1 agonist DPDPE (0.5 mg/kg), and kappa agonist (-)-U-50.488 (1 mg/kg) increases rat myocardial resistance to arrhythmogenic effect
[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation]
Autor:
S A, Bogomaz, L N, Maslov, A V, Krylatov, N V, Solenkova, A Iu, Lishmanov, E V, Budankova, G J, Grover
Publikováno v:
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. 89(4)
It has been found that pretreatment with ATP-dependent potassium channel (KATP-channel) opener, BMS 180448 (3 mg/kg, intravenously), increases cardiac resistance against arrhythmogenic action of coronary artery occlusion and reperfusion in anaestheti
Autor:
L N, Maslov, A V, Krylatov, N V, Naryzhaia, N V, Solenkova, A Iu, Lishmanov, S A, Bogomaz, G J, Gross, J B, Stefano, B A, Loktiushina
Publikováno v:
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. 88(7)
It has been shown that mu-opioid receptor stimulation by intravenous administration of the selective mu receptor agonist DALDA in a dose of 0.1 mg/kg prevented ischemic and reperfusion arrhythmias in rats subjected to coronary artery occlusion (10 mi
Autor:
N V, Solenkova, L N, Maslov, Iu B, Lishmanov, V Iu, Serebrov, S A, Bogomaz, G G, Gross, J B, Stefano, S V, Tam
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 65(1)
Preliminary administration of the delta 1-opioid receptor (delta 1-OR) selective peptide agonist DPDPE (0.1 mg/kg, i.v.) increased the ventricular fibrillation threshold (VFT) in postinfarction cardiosclerosis in rats. Pretreatment with the selective
Autor:
L N, Maslov, A V, Krylatov, A Iu, Lishmanov, Iu K, Podoksenov, N V, Solenkova, S A, Bogomaz, S W, Tam, G J, Gross
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 64(6)
Preliminary administration of the delta 1-opioid receptor (delta 1-OR) peptide agonist DPDPE (0.5 mg/kg, i.v.) decreased the incidence of occlusion (10 min) and reperfusion (10 min) arrhythmias in rats. The delta 2-OR agonist DSLET did not affect arr
Autor:
L N, Maslov, T V, Lasukova, N V, Solenkova, A Iu, Lishmanov, S A, Bogomaz, S V, Tam, G J, Gross
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 64(5)
Preliminary administration of the mu-opioid receptor (mu-OR) agonist DAMGO (0.1 mg/kg) 15 min before heart isolation led to attenuation of the postischemic systolic and diastolic contractility dysfunction in isolated perfused rat heart. In addition,
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 64(2)
The cardioselective KATP channel activator BMS 180448 (3 mg/kg) administered intravenously 15 min before the coronary artery occlusion (10 min) decreased the incidence of ischemic and reperfusion arrhythmias in rats. A similar antiarrhythmic effect w